Digital Therapeutics for Anxiety: What the App-Based Treatment Evidence Shows
Smartphone apps and online programs for anxiety have proliferated, but the evidence ranges from well-supported to non-existent.
There are thousands of mental health apps available. Many claim to help with anxiety. Some are backed by randomized trials; most are not. The distance between the best-studied digital treatments and the average app in the store is enormous, and understanding that distance matters for making an informed choice.
The spectrum of digital treatments
Digital therapeutics for anxiety range widely in format, intensity and evidence:
Guided internet CBT. Structured, multi-session programs delivered online with regular therapist support (typically asynchronous messaging or brief calls). Examples include programs from research groups in Sweden, Australia and the Netherlands that have been tested in dozens of trials.
Unguided internet CBT. The same structured programs, but without therapist contact. The patient works through the modules independently.
Smartphone apps. Standalone apps offering exercises, tracking, guided meditations, chatbot conversations or brief CBT-based techniques. These range from well-designed products with some evidence to products with no evidence and questionable design.
Virtual reality exposure. VR-based tools for specific phobias and social anxiety, typically used in a clinical setting rather than independently.
Chatbots. AI-driven conversational agents that simulate therapeutic interactions.
Where the evidence is strong: guided internet CBT
The strongest evidence in digital mental health is for guided internet CBT. A meta-analysis of 20 trials that directly compared internet CBT with face-to-face CBT for various conditions found equivalent outcomes [1]. The pooled difference was essentially zero, with the confidence interval spanning a very small range on either side.
An earlier meta-analysis of computer-delivered CBT for anxiety and depression found large effect sizes compared with control conditions, with guided programs consistently outperforming unguided ones [6].
These are not fringe findings. Guided internet CBT for anxiety is recommended in NICE guidelines and is part of the IAPT program in England. The programs are structured (typically 8–12 modules), based on established CBT protocols, and include regular therapist check-ins. They are, essentially, conventional CBT delivered through a different medium.
Where the evidence weakens: unguided programs and apps
Remove the therapist, and the picture changes. A systematic review and meta-analysis of standalone smartphone apps for mental health found a small overall effect on depression but no significant effect on anxiety compared with control conditions [3]. The number of anxiety-specific trials was small, and the quality was variable.
A meta-analysis of acceptance, mindfulness and compassion-based apps found small effects on anxiety symptoms, but noted high heterogeneity and the predominance of waitlist comparisons [2].
The consistent finding across the literature is that guidance matters. Programs with therapist support produce larger effects, have lower dropout rates and show more durable gains. The guidance need not be intensive — brief weekly messages or calls often suffice — but its presence is a reliable moderator.
The dropout problem
High dropout is the single biggest challenge in digital mental health. A meta-analysis of smartphone app trials for depression found an average dropout rate of about 47%, with some trials exceeding 70% [4]. Anxiety app trials show similar patterns.
This creates an interpretive problem. If only 30% of participants complete the program, the positive results apply to that 30%, not to everyone who downloaded the app. The people who drop out may be those for whom the app was not helpful, or those who were too impaired to engage, or simply those who found it boring. The per-protocol results (analyzing only completers) look better than the intention-to-treat results (analyzing everyone who started), and the gap between the two is often large.
What FDA clearance means
Several digital therapeutics for mental health have received FDA clearance in the US. This is sometimes presented as validation that they “work.” The reality is more complicated.
FDA clearance for digital therapeutics typically uses the 510(k) or De Novo regulatory pathway, which requires demonstrating that the product is safe and has some evidence of effectiveness. The evidentiary bar is lower than for drug approval. Some cleared products have supporting RCTs; others have been cleared based on predicate devices or limited evidence.
An assessment of commercially available digital therapeutics found that many lacked adequate published evidence, and that marketing claims often outpaced the supporting data [5]. “FDA-cleared” is not equivalent to “proven effective in a rigorous independent trial.”
How to evaluate an anxiety app
If you are considering a digital treatment for anxiety, the following questions can help separate evidence from marketing:
- Is there a published RCT of this specific product? Not of CBT in general, not of apps in general, but of this app. Check PubMed or the company’s website.
- What was the comparison? A trial against waitlist tells you the app is better than nothing. A trial against an active comparison is more informative.
- What was the dropout rate? If more than half the participants stopped using it, the results represent a self-selected minority.
- Was the trial independent? Trials conducted by the company that makes the product are subject to the same allegiance effects as any researcher-led trial.
- Is guidance included? If the trial tested a guided version and the product you’re buying is unguided, the evidence may not apply.
What this means
The digital treatment landscape for anxiety contains genuinely effective interventions (guided internet CBT), promising but less proven ones (some unguided programs and apps) and a large volume of untested products. The most important distinction is not between “digital” and “traditional” but between “tested” and “untested.”
For how to evaluate treatment evidence more broadly, see what a Cochrane review tells you. For the related question of whether online therapy matches in-person therapy, see online versus in-person therapy.
When to look for more support. A well-supported digital program can be a good first step or a complement to other treatment. But if your anxiety is severe or worsening, an app is not a substitute for professional care. Talk to your GP or a psychologist. If you are in crisis, call or text 988 (US) or Samaritans on 116 123 (UK and Ireland).
Frequently asked questions
Do anxiety apps work?
It depends on which app and what you mean by 'work.' Guided internet CBT programs with therapist support have strong evidence, comparable to face-to-face therapy in some trials. Unguided smartphone apps have much weaker evidence, with smaller effects and high dropout rates. Most commercial anxiety apps have no published evidence of effectiveness.
What is the difference between guided and unguided digital treatment?
Guided programs include regular contact with a therapist or trained supporter, typically by message or brief phone calls. Unguided programs are entirely self-directed. The guidance is a consistent moderator of effect: guided programs produce larger effects. The guidance may provide accountability, personalization and a therapeutic relationship.
What does FDA clearance mean for a digital therapeutic?
FDA clearance (typically through the 510(k) or De Novo pathway) means the device is considered safe and has some evidence of benefit, but the evidentiary bar is lower than for drug approval. Some cleared digital therapeutics have randomized trial evidence; others have been cleared based on predicate devices or limited clinical data. Clearance does not mean the same thing as proven effective in a rigorous trial.
How can I tell if an anxiety app has evidence?
Look for published, peer-reviewed randomized controlled trials of that specific app, not of the general approach it claims to use. An app that says it uses 'CBT techniques' is not the same as an app tested in a trial. Check whether the trial used an active comparison or only a waitlist. Look at the dropout rate: if 70% of participants stopped using the app, the results apply mainly to the minority who persisted.
Sources and further reading
- Carlbring, Andersson, Cuijpers, Riper and Hedman-Lagerlöf — Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis
Cognitive Behaviour Therapy, 2018;47(1):1–18. 20 trials directly comparing internet and face-to-face CBT. DOI: 10.1080/16506073.2017.1401115.
- Linardon — Can acceptance, mindfulness, and compassion-based interventions for mental health be delivered through smartphone apps? A systematic review and meta-analysis
Journal of Affective Disorders, 2020;276:944–955. Meta-analysis of smartphone-based interventions. DOI: 10.1016/j.jad.2020.07.108.
- Weisel et al. — Standalone smartphone apps for mental health — a systematic review and meta-analysis
npj Digital Medicine, 2019;2:118. 19 RCTs of standalone apps. DOI: 10.1038/s41746-019-0188-8.
- Torous, Lipschitz, Ng and Firth — Dropout rates in clinical trials of smartphone apps for depressive symptoms: a systematic review and meta-analysis
Journal of Affective Disorders, 2020;263:413–419. Dropout rates in app trials. DOI: 10.1016/j.jad.2019.11.167.
- Lau, Haslam, Prior and Burr — Adequacy of evidence for commercially available digital therapeutics
BMJ Medicine, 2023;2(1):e000436. Assessment of evidence behind marketed digital therapeutics. DOI: 10.1136/bmjmed-2022-000436.
- Andrews, Cuijpers, Craske, McEvoy and Titov — Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis
PLoS ONE, 2010;5(10):e13196. Early meta-analysis of computer-based CBT. DOI: 10.1371/journal.pone.0013196.
Sources checked October 16, 2026. This is an editorial summary, not a systematic review or individual advice.